James Christopher Barry - 21 Jun 2021 Form 4 Insider Report for NUVASIVE INC

Role
Chief Executive Officer, Director
Signature
/s/ Nathaniel B. Sisitsky, Attorney-in-fact for James Christopher Barry
Issuer symbol
N/A
Transactions as of
21 Jun 2021
Net transactions value
-$340,000
Form type
4
Filing time
23 Jun 2021, 17:53:21 UTC
Next filing
29 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVA Common Stock Sale $340,000 -5,000 -25% $68.00 14,926 21 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
F2 Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards.